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This study examined the association between consumption of alcoholic beverages and all-cause and cardiovascular disease (CVD)
mortality in a cohort of men (n = 31,367). In the Cox proportional hazards model adjusted for age, year of examination, body
mass index (BMI), smoking, family history of CVD, and aerobic fitness, there were no significant diﬀerences in risk of all-cause
mortality across alcohol intake groups. Risk of CVD mortality was reduced 29% in quartile 1 (HR = 0.71, 95% confidence interval
(CI): 0.53, 0.95) and 25% in quartile 2 (HR = 0.75, 95% CI: 0.58, 0.98). The amount of alcohol consumed to achieve this risk
reduction was <6 drinks/week; less than the amount currently recommended. The addition of other potential confounders and
eﬀect modifiers including blood pressure, insulin sensitivity, lipid levels, and psychological variables did not aﬀect the magnitude
of association. Future research is needed to validate the current public health recommendations for alcohol consumption.

1. Introduction
Light-to-moderate alcohol consumption has been shown in
several prospective studies to reduce the risk of all-cause
mortality and several cardiac outcomes, including cardiovascular disease (CVD) mortality in men [1–10]. Several
hypotheses exist for the mechanism of this protective eﬀect
including increased exposure to antioxidants, improved
lipid profiles, reduced insulin resistance, decreased blood
coagulation, and modified inflammation pathways [11, 12].
Despite a large number of studies examining alcohol
consumption and mortality, questions remain about the
nature of this relationship. Three primary concerns include
the influence of confounding factors, appropriate public
health recommendations, and diﬀerential eﬀects between
types of alcohol [13, 14]. Selection bias is a particular
concern when comparing nondrinkers to drinkers. Nondrinkers may abstain from alcohol because of an initial health
condition and be more likely to have other conditions that
might confound the relationship including obesity, physical

inactivity, and overall health problems [14]. In addition,
moderate alcohol consumption has been associated with
positive psychosocial outcomes including sociability and
stress reduction, which may further confound the association
with mortality [15, 16]. Confounding is a limitation of
nonexperimental studies, yet it is unethical and impractical
to conduct long-term randomized controlled trials of alcohol
consumption. In an attempt to address this challenge,
investigators have used statistical methods to control for
possible confounders that may increase the risk of mortality
independent of alcohol consumption, but that may be
diﬀerentially distributed in those who drink alcohol versus
those who do not, such as smoking or physical inactivity.
Several problems have hampered the ability to construct
an appropriate public health message about alcohol consumption. Methodological variation has led to inconsistent
estimates of protective amounts of alcohol and, thus, an
inability to quantify safe recommendations [17]. In addition,
any protective eﬀect must simultaneously be weighed against

2
potential negative consequences. While several studies support light-to-moderate alcohol consumption as a protective
factor against CVD and all-cause mortality, excessive alcohol
intake has been associated with increased triglycerides, high
blood pressure, risk of some cancers, liver cirrhosis, heart
failure, and all-cause mortality [9, 12, 18]. Also, certain
cancers (e.g., breast) may be associated with increased risk
at low doses, but no dose response thereafter [19–21]. As
a result of these conflicting messages, the public may be
confused about the relationship between alcohol and health
outcomes.
The purpose of this study was to analyze the relationship between alcohol consumption and all-cause and
CVD mortality in a cohort of men while considering a
variety of potential confounding and modifying risk factors.
Additionally, diﬀerential eﬀects of types of alcohol on these
health outcomes were investigated.

2. Materials and Methods
2.1. Study Participants. Study participants were from the
Aerobics Center Longitudinal Study (ACLS) [22], a prospective epidemiological study of health outcomes in USA
adults. The sample for the current analyses was limited to
men, the majority of whom were white, middle to upper
income, received a baseline examination at the Cooper
Clinic in Dallas, Texas between 1974 and 2002 with at least
one year of followup, were aged ≥20 years at baseline,
were free of known CVD, cancer, or abnormal ECG, and
had complete information on alcohol intake and maximal
exercise treadmill test. Individuals participating in the ACLS
were either referred to the clinic by their employers or
physicians or through self-referral. The study was annually
reviewed and approved by the Cooper Institute Institutional
Review Board, and all participants gave written informed
consent for the baseline clinical examination and follow-up.
2.2. Primary Exposure Variable. Alcohol intake in drinks
per week among participants was self-reported at baseline.
Participants were asked, “How many 12-ounce drinks of
beer, 3-ounce drinks of wine (5-ounce drinks of wine during
more recent data collection cycles), and/or 1.5-ounce drinks
of hard liquor do you consume per week?” Self-report
alcohol intake has been previously validated against dietary
records in men (r = 0.86) [23, 24]. Participants were then
classified either as nondrinkers, or in quartiles of drinkers
based on baseline alcohol drinking reports.
2.3. Outcome Variables. All participants were followed from
the date of their baseline examination until their death or
December 31, 2003. Mortality surveillance was primarily
through the National Death Index. CVD mortality was
defined as the International Classification of Diseases, Ninth
Revision codes 390 to 449.9 before 1999 and Tenth Revision
codes I00 to I78 during 1999–2003.
2.4. Covariates. The baseline clinical assessment has been
previously described in detail [22, 25, 26]. At the baseline
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visit patients completed a written survey and anthropometric, blood pressure, blood chemistry, and electrocardiogram
measures. Body Mass Index [BMI = weight (kg)/height (m)2 ]
was calculated from height and weight. Resting blood pressure was assessed via ascultatory method [27]. Blood samples
were drawn after a 12-hour overnight fast, and analyzed for
fasting glucose and cholesterol using automated bioassays
according to the Centers for Disease Control and Prevention
Lipid Standardization Program. Hypertension, hypercholesterolemia, and diabetes were defined according to clinical
thresholds or self-reported as a previous diagnosis from
a physician. Hypertension was defined as resting systolic
or diastolic blood pressure ≥140/90 mmHg, hypercholesterolemia was defined as total cholesterol ≥240 mg/dL [28],
and diabetes was defined as fasting glucose ≥126 mg/dL [29].
The questionnaire included questions on smoking habits,
family history of CVD, and the presence of neuropsychiatric
conditions including anxiety, depression, suicidal thoughts,
or psychological counseling. Cardiorespiratory fitness (CRF)
was assessed using symptom-limited maximal treadmill
time during the modified Balke Protocol [22, 30]. Test
termination occurred by participant volition or physician
determined medical reasons. Test duration has been strongly
correlated with maximal oxygen uptake (r = 0.92) [31].
Cardiorespiratory fitness is a quantifiable, objective measure
with stronger associations to future health outcomes than
self-reported physical activity [32]. Treadmill times were
classified into fitness quintiles with the first quintile classified
as unfit and the remaining four quintiles as fit [33].
2.5. Statistical Analysis. Cox proportional hazards models
were used to calculate hazard ratios (HRs) and associated
95% confidence intervals. Alcohol consumption was the
primary exposure of interest. All-cause and CVD mortality
were fit as the outcomes (i.e., death or not, and time to event
or censoring) for survival analysis. Nondrinkers were used
as the referent group and those classified as drinkers were
categorized into quartiles of exposure. Linear and quadratic
trends were tested by fitting the continuous variable of
alcohol consumption in the basic model for both all-cause
and cardiovascular disease mortality. The basic model was
adjusted for age (in years), year of examination, BMI,
smoking (current smoker or not), family history of CVD
(yes or no), and treadmill time (minutes). Because blood
pressure [34], insulin sensitivity [35], and lipid levels [36]
have been shown to mediate the relationship between alcohol
and CVD mortality, they were added individually and then
simultaneously into the basic model. Finally, the full model
was adjusted for psychological variables [15, 16].
To examine eﬀect modification due to other health
risk factors, multivariate stratified analyses were conducted
for dichotomies based on age (<60 and ≥60 years), BMI
(<25 and ≥25 kg/m2 ), health status (healthy and unhealthy
defined as having at least one of the following diseases:
hypertension, diabetes, or hyperlipidemia), and fitness (least
fit 20% and most fit 80%) to test for eﬀect modification.
These models were adjusted for year of examination, smoking, family history of CVD, and age, BMI, health status, and
fitness where appropriate.
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After analyzing the overall eﬀect of alcohol on mortality,
separate analyses were run for each type of alcohol (beer,
wine, and liquor), because of the potential diﬀerential eﬀects
from diﬀerent types of alcohol. As there were few men who
consumed a single beverage type, analysis was conducted
separately for quartiles of a single type of alcohol while
adjusting for the remaining type of alcohol consumption
[37, 38]. Alcohol consumption quartiles were created independently for each alcohol type and hazard ratios adjusted
for age, year of examination, BMI, smoking, family history
of CVD, maximal treadmill time, and remaining types of
alcohol were calculated using nondrinkers as the reference
group.

3. Results and Discussion
A total of 31,637 men were included in the sample. The mean
age of men at baseline was 42.9 (standard deviation (SD):
9.2) years. Baseline characteristics are presented in Table 1.
Mean follow-up time was 16.0 (8.3) years for a total
of 504,735 person-years. There were 1,834 total deaths
and 588 CVD deaths. The rate of all-cause and CVD
mortality was calculated for the five drinking categories:
nondrinkers, quartile 1 (1–3 drinks/week), quartile 2 (4–6
drinks/week), quartile 3 (7–13 drinks/week), and quartile
4 (≥14 drinks/week). Alcohol consumption was linearly
associated with both all-cause and CVD mortality rate (P =
0.002 and P = 0.02).
3.1. Primary Analysis. In the basic model adjusted for age,
year of examination, BMI, smoking, family history of CVD,
and fitness, there were no significant diﬀerences in all-cause
mortality risks across alcohol intake groups (Table 2). There
was a lower risk of CVD mortality in quartile 1 (HR = 0.71,
95% confidence interval (CI): 0.53, 0.95) and quartile 2 (HR
= 0.75, 95% CI: 0.58, 0.98) in the basic model which is
less than 6 drinks per week (see Table 3). The addition of
potential intermediate variables of glucose, lipids, and blood
pressure, or the inclusion of all three, did not attenuate these
relationships. The additional adjustment for psychological
variables did not alter the observed associations and are not
included in the results presented.
3.2. Stratified Analysis. The lower risk of all-cause mortality
from light drinking (quartile 1) was attenuated when the
results were stratified by BMI, health status, and fitness (see
Table 4). However, men younger than 60 years in quartile 1
exhibited a significantly lower risk of all-cause mortality (HR
= 0.80, 95% CI: 0.66, 0.96); whereas, men 60 or older did not.
For CVD mortality, there were no significant findings
in men who were ≥60 years, had a BMI < 25 kg/m2 , were
healthy, or unfit (see Table 5). Younger men had lower risk of
CVD mortality in quartile 1 (HR = 0.59, 95% CI: 0.43, 0.83)
and quartile 2 (HR = 0.70, 95% CI: 0.52, 0.93). Men with a
BMI >25 kg/m2 had lower CVD mortality risk in quartile 1
(HR = 0.67, 95% CI: 0.47, 0.94) and quartile 2 (HR = 0.71,
95% CI: 0.52, 0.97). Unhealthy men had a reduced risk in
quartile 3 (HR = 0.74, 95% CI: 0.54, 0.998). When stratified
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by fitness, fit men exhibited a lower risk in quartile 2 (HR =
0.69, 95% CI: 0.49, 0.96).
3.3. Type of Alcohol. The results of the sensitivity analysis are
listed in Table 4. There were a total of 26,767 drinkers, of
which 23,728 reported drinking beer, 21,997 reported drinking wine, and 20,416 reported drinking liquor. Therefore, for
this analysis, the types of alcohol drinking are not exclusive.
For all-cause mortality, there were no significant diﬀerences
in risk for any three of the alcohol types in comparison to
nondrinkers (see Table 6). For CVD mortality, there was a
lower risk with beer consumption in quartile 3 (HR = 0.72,
95% CI: 0.52, 0.995), wine consumption in quartile 2 (HR =
0.70, 95% CI: 0.53, 0.93) and liquor consumption in quartile
2 (HR = 0.71, 95% CI: 0.50, 0.93) and Q3 (HR = 0.69, 95%
CI: 0.55, 0.93) (see Table 7).

4. Discussion
4.1. All-Cause Mortality. In the current study, the relationship between risk of all-cause mortality with alcohol
consumption appeared to evince a flattened J-shaped curve
pattern. However, the risk reductions were significant only
at the lowest levels of alcohol consumption. Other studies
reporting on the association of alcohol consumption and
all-cause mortality in men have found protective eﬀects up
to three drinks per day [5]. In the Physicians Health Study,
Gaziano et al [3], found a reduction in all-cause mortality
with 5 to 6 drinks/week and reductions in CVD mortality
with all levels of alcohol consumption. Gaziano’s results are
consistent with a meta-analysis conducted by Di Castelnuovo
[39] which found a reduced risk for all-cause mortality up to
4 drinks per day.
4.2. Cardiovascular Disease Mortality. It has been hypothesized that the lower CVD mortality risk associated with
limited alcohol intake is due to the cardioprotective eﬀects of
alcohol such as improved lipid profiles and decreased blood
coagulation [11, 12]. CVD contributes to 34.3% of all deaths
in the nation and is an important health outcome [40];
therefore, our results warrant consideration. In this sample,
32% of all deaths were attributed to CVD, similar to the
nationwide estimates. There was a 29% and 25% reduction
in risk for CVD mortality in the first and second quartiles of
alcohol consumption, respectively. This risk reduction was
found for 1–6 drinks per week. The lower risk of CVD death
may be balanced with an increase in other causes of death
potentially due to alcohol consumption, again complicating
public health recommendations.
The lower CVD mortality risk we observed was not attenuated when potential intermediate factors of blood pressure,
lipids, and glucose were added to the model, suggesting the
lower risks were not mediated by these factors. While Suh et
al. [7] and Djoussé et al. [41] found that the reduced risk of
CVD mortality in women was mediated by lipids and insulin
sensitivity, other authors have found the relationship to be
independent of these risk factors. Arriola et al. [1] found
that blood pressure, cholesterol, and diabetes did not alter
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Table 1: Baseline demographics by alcohol consumption level, Aerobics Center for Longitudinal Study (ACLS), 1974–2002.

n
Age (years)
Alcohol (drinks/week)
Body mass index (kg/m2 )
Maximal treadmill time (min)
Current smokers (%)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Hypertension (%)a
Fasting glucose (mg/dL)
Diabetes (%)b
Total cholesterol (mg/dL)
Triglycerides (mg/dL)
Hyperlipidemia (%)c
Unhealthy (%)d
Family history of CVD (%)

Nondrinkers (0)
4870
43.63 (9.65)
0
26.65 (4.29)
17.24 (5.15)
10.62
121 (13)
81 (10)
30.86
99.14 (18.92)
4.58
205.80 (38.56)
141.09 (104.59)
29.49
49.63
26.96

Alcohol consumption (drinks/week)
Quartile 1 (1–3)
Quartile 2 (4–6)
Quartile 3 (7–13)
6733
6150
6841
42.15 (9.15)
42.34 (9.07)
42.95 (9.23)
2.01 (0.76)
5.00 (0.87)
9.65 (1.93)
26.63 (4.02)
26.36 (3.65)
26.28 (3.45)
18.33 (4.89)
18.14 (4.90)
18.50 (4.84)
14.18
19.50
22.03
121 (13)
121 (13)
121 (13)
80.91 (9.47)
80.52 (9.35)
81.17 (9.41)
28.32
28.10
30.35
99.20 (16.52)
98.80 (14.50)
99.74 (14.50)
4.92
4.70
4.37
203.21 (39.88)
205.42 (38.29)
209.58 (39.16)
137.20 (106.77)
132.02 (94.37)
134.63 (101.78)
26.56
26.03
28.46
46.81
45.69
48.68
23.91
25.45
24.69

Quartile 4 (≥14)
7043
43.62 (9.13)
24.62 (13.64)
26.42 (3.35)
17.78 (4.83)
29.09
122 (13)
81.90 (9.53)
34.49
101.13 (14.19)
4.91
217 (40.42)
144.54 (105.24)
35.57
55.93
28.44

a

Defined as systolic or diastolic blood pressure ≥140/90 mmHg or history of physician diagnosis.
as fasting glucose ≥126 mg/dl or history of physician diagnosis.
c Defined as fasting total cholesterol ≥240 mg/dl or triglyceride ≥200 mg/dL.
d Defined as presence of one or more of following diseases: hypertension, diabetes, or hyperlipid.
b Defined

Table 2: Hazard ratios of all-cause mortality by alcohol consumption level in men, Aerobics Center for Longitudinal Study (ACLS), 1974–
2002.

Person-years
No.
No. of Deaths
Death ratea
Basic modelb
Basic model plus
Blood pressure factorsc
Fasting glucose factorsd
Lipid factorse
All intermediate factorscde

Nondrinkers (0)
86,872
4870
343
43.8
1.00 (referent)
1.00 (referent)
1.00 (referent)
1.00 (referent)
1.00 (referent)

Alcohol consumption (drinks/week)
Quartile 1 (1–3)
Quartile 2 (4–6)
Quartile 3 (7–13)
91,529
98,303
103,625
6733
6150
6841
237
350
349
37.2
43.3
41.6
0.86 (0.73–1.01)
0.95 (0.82–1.10)
0.97 (0.83–1.12)

Quartile 4 (≥14)
124,360
7043
555
51.2
1.09 (0.95–1.25)

0.86 (0.73–1.02)
0.84 (0.71–0.99)
0.86 (0.73–1.01)
0.84 (0.71–0.99)

1.06 (0.92–1.21)
1.07 (0.94–1.23)
1.09 (0.95–1.25)
1.05 (0.91–1.20)

0.94 (0.81–1.09)
0.95 (0.82–1.10)
0.95 (0.82–1.11)
0.94 (0.81–1.09)

0.97 (0.83–1.12)
0.96 (0.82–1.11)
0.96 (0.83–1.12)
0.96 (0.82–1.11)

a

Death rate per 10,000 person-years adjusted for age (in years).
for age (in years), year of examination, BMI (kg/m2 ), smoking (current smoker or not), family history of CVD (yes or no), and maximal treadmill
time (min).
c Systolic blood pressure and reported hypertension (yes or no).
d Fasting glucose and reported diabetes (yes or no).
e Total cholesterol and triglyceride.
b Adjusted

their results and, through coronary angiography, Femia et al.
[42] found the risk for atherosclerosis and cardiac mortality
was independent of cholesterol, hypertension, and diabetes.
More research is needed to study the potential mechanisms
of alcohol intake on reduced CVD mortality risk.
4.3. Public Health Recommendations. Our results do not
support the currently recommended intake of 1-2 drinks
per day for men from the American Heart Association [43].
The lower alcohol consumption for risk reduction in our

study may result from complete adjustment for confounders
including fitness and thorough screening resulting in exclusion of preclinical cases. There are large variations in results
from prospective studies examining alcohol consumption
and mortality making it diﬃcult to compare findings for
universal alcohol recommendations. In Di Castelnuovo et
al.’s [39] meta-analysis of all-cause mortality, they found
diﬀerences among genders, countries of the study, and
number of confounders. There has been large variation in
methods of reporting and categorizing alcohol consumption.
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Table 3: Hazard ratios of CVD mortality by alcohol consumption level in men, Aerobics Center for Longitudinal Study (ACLS), 1974–2002.

Person-years
No.
No. of Deaths
Death ratea
Basic modelb
Basic model plus
Blood pressure factorsc
Fasting glucose factorsd
Lipid factorse
All intermediate factorscde

Alcohol consumption (drinks/week)
Quartile 1 (1–3)
Quartile 2 (4–6)
Quartile 3 (7–13)
91,529
98,303
103,625
6663
6049
6735
70
101
106
11.6
13.1
12.9

Quartile 4 (≥14)
124,360
6860
183
17.7

1.00 (referent)

0.71 (0.53–0.95)

0.75 (0.58–0.98)

0.83 (0.64–1.08)

1.00 (0.80–1.26)

1.00 (referent)
1.00 (referent)
1.00 (referent)
1.00 (referent)

0.70 (0.53–0.94)
0.68 (0.51–0.91)
0.71 (0.53–0.95)
0.68 (0.51–0.91)

0.73 (0.56–0.95)
0.75 (0.58–0.98)
0.73 (0.56–0.96)
0.71 (0.55–0.93)

0.84 (0.64–1.09)
0.82 (0.63–1.07)
0.80 (0.62–1.04)
0.81 (0.62–1.05)

0.94 (0.75–1.18)
0.98 (0.78–1.24)
0.95 (0.75–1.19)
0.88 (0.69–1.11)

Nondrinkers (0)
86,872
4742
128
17.0

a

Death rate per 10,000 person-years adjusted for age (in years).
for age (in years), year of examination, BMI (kg/m2 ), smoking (current smoker or not), family history of CVD (yes or no), and maximal treadmill
time (min).
c Systolic blood pressure and reported hypertension (yes or no).
d Fasting glucose and reported diabetes (yes or no).
e Total cholesterol and triglyceride.
b Adjusted

Table 4: Hazard ratios of all-cause mortality stratified by risk factorsa , Aerobics Center for Longitudinal Study (ACLS), 1974–2002.
Alcohol consumption (drinks/week)
Quartile 1 (1–3)
Quartile 2 (4–6)
Quartile 3 (7–13)

Quartile 4 (≥14)

1.00 (referent)
1.00 (referent)

0.80 (0.66–0.96)
0.86 (0.59–1.25)

0.92 (0.78–1.09)
0.85 (0.59–1.23)

1.02 (0.86–1.20)
0.75 (0.52–1.08)

1.08 (0.93–1.26)
1.04 (0.76–1.44)

1.00 (referent)
1.00 (referent)

0.85 (0.65–1.11)
0.86 (0.70–1.06)

1.03 (0.80–1.32)
0.90 (0.75–1.09)

0.95 (0.74–1.22)
0.96 (0.79–1.16)

0.97 (0.77–1.23)
1.12 (0.95–1.33)

1.00 (referent)
1.00 (referent)

0.91 (0.69–1.20)
0.82 (0.67–1.01)

0.92 (0.71–1.19)
0.97 (0.81–1.17)

1.10 (0.86–1.42)
0.88 (0.73–1.07)

1.11 (0.87–1.41)
1.05 (0.89–1.24)

1.00 (referent)
1.00 (referent)

0.91 (0.67–1.22)
0.84 (0.69–1.03)

1.02 (0.79–1.32)
0.91 (0.76–1.10)

1.10 (0.83–1.44)
0.87 (0.73–1.05)

1.17 (0.92–1.48)
1.01 (0.85–1.19)

Nondrinkers (0)
Age
Age <60 (n = 30, 263)
Age ≥60 (n = 1, 374)
BMI
BMI <25 (n = 12, 037)
BMI ≥25 (n = 19, 600)
Health statusb
Healthy (n = 15, 989)
Unhealthy (n = 15, 648)
Fitness level
Unfit (least fit 20%) (n = 5, 238)
Fit (most fit 80%) (n = 26, 399)
a

Adjusted for year of examination, smoking (current smoker or not), family history of CVD (yes or no), and each other factor in the table.
as presence or absence of one or more of following diseases: hypertension, diabetes, or hyperlipidemia.

b Defined

Various authors have used diﬀerent definitions of drinks
ranging from 8 grams of alcohol per drink [10] to 22.8
grams [6]. Therefore, we did not attempt to impose grams of
alcohol conversion factors on self-reported drinks per week.
There is additional complexity when looking at the myriad of
cardiovascular outcomes. Previous studies have used various
outcomes including CVD mortality, cardiac mortality, CHD,
and myocardial infarction. For example, Beulens et al. [37]
found a reduction in risk of myocardial infarction, but not
in all-cause or CVD mortality. Due to such variation, it is
challenging to establish widespread recommendations for a
safe or protective amount of alcohol consumption as related
to CV health.
While a decrease in risk of all-cause mortality with
alcohol consumption was not found in this sample, there was
not a significantly increased risk with the highest amounts

of self-reported alcohol consumption. Klatsky [12] defined
heavy drinking as greater than 3 drinks per day, which is
consistent with the mean 24 drinks per week found in the
highest quartile of alcohol consumption in this study. While
our sample did not show a higher risk of either all-cause
or CVD mortality with the highest alcohol consumption,
there are other concerns in recommending drinking alcohol
including potential alcohol abuse. Rehm et al. [44] estimated
12.1% of disability-adjusted life years for men in the US were
attributed to alcohol-related causes with an estimated cost
of $235 billion dollars. Of problem drinkers, 82% report
drinking the moderate amount recommended to protect
against CVD [17]. Alcohol may be harmful in many ways,
even in small amounts (e.g., as a cocarcinogen with tobacco
smoke) [45].
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Table 5: Hazard ratios of CVD mortality stratified by risk factorsa , Aerobics Center for Longitudinal Study (ACLS), 1974–2002.
Alcohol consumption (drinks/week)
Quartile 1 (1–3)
Quartile 2 (4–6)
Quartile 3 (7–13)

Quartile 4 (≥14)

1.00 (referent)
1.00 (referent)

0.59 (0.43–0.83)
1.07 (0.57–2.00)

0.70 (0.52–0.93)
0.82 (0.43–1.57)

0.78 (0.58–1.04)
1.06 (0.59–1.91)

0.85 (0.66–1.11)
1.53 (0.92–2.54)

1.00 (referent)
1.00 (referent)

0.80 (0.47–1.37)
0.67 (0.47–0.94)

0.84 (0.51–1.39)
0.71 (0.52–0.97)

0.76 (0.46–1.25)
0.82 (0.60–1.11)

1.02 (0.66–1.59)
0.91 (0.69–1.19)

1.00 (referent)
1.00 (referent)

0.61 (0.32–1.16)
0.73 (0.52–1.01)

0.73 (0.42–1.28)
0.76 (0.56–1.02)

1.06 (0.63–1.79)
0.74 (0.54–0.998)

1.18 (0.72–1.92)
0.90 (0.69–1.17)

1.00 (referent)
1.00 (referent)

0.65 (0.39–1.08)
0.72 (0.51–1.04)

0.80 (0.52–1.22)
0.69 (0.49–0.96)

0.80 (0.50–1.27)
0.73 (0.53–1.00)

1.00 (0.68–1.44)
0.89 (0.67–1.19)

Nondrinkers (0)
Age
Age < 60 (n = 30, 263)
Age ≥ 60 (n = 1, 374)
BMI
BMI < 25 (n = 12, 037)
BMI ≥ 25 (n = 19, 600)
Health statusb
Healthy (n = 15, 989)
Unhealthy (n = 15, 648)
Fitness level
Unfit (least fit 20%) (n = 5, 238)
Fit (most fit 80%) (n = 26, 399)
a

Adjusted for year of examination, smoking (current smoker or not), family history of CVD (yes or no), and each other factor in the table.
as presence or absence of one or more of following diseases: hypertension, diabetes, or hyperlipidemia.

b Defined

Table 6: Hazard ratios of all-cause mortality stratified by types of alcohol beveragea , Aerobics Center for Longitudinal Study (ACLS), 1974–
2002.

Beer (n = 23, 728)
No.
No. of Cases
Hazard ratios
Wine (n = 21, 997)
No.
No. of Cases
Hazard ratios
Liquor (n = 20, 416)
No.
No. of Cases
Hazard ratios

Alcohol consumption (drinks/week)
Quartile 2
Quartile 3

Nondrinkers

Quartile 1

Quartile 4

4870
343
1.00 (referent)

3854
147
0.87 (0.71, 1.06)

4876
362
0.99 (0.84, 1.16)

5779
227
0.90 (0.75, 1.07)

4349
237
1.15 (0.96, 1.37)

4870
343
1.00 (referent)

4091
177
0.87 (0.72, 1.05)

4999
370
0.92 (0.79, 1.08)

4175
183
0.88 (0.73, 1.07)

3862
196
0.95 (0.78, 1.14)

4870
343
1.00 (referent)

3111
126
0.93 (0.75, 1.14)

5022
383
0.96 (0.82, 1.12)

3562
247
0.89 (0.75, 1.06)

3851
423
1.13 (0.97, 1.32)

ACLS: Aerobics Center Longitudinal Study.
a Adjusted for age (in years), year of examination, BMI (kg/m2 ), smoking (current smoker or not), family history of CVD (yes or no), maximal treadmill time
(min), and remaining type of alcohol.

4.4. Stratified Analysis. The lower risk for all-cause mortality
was attenuated when stratified by BMI and health status,
but remained significant in younger men, consistent with
stratified results found by Sun et al. [8]. A meta-analysis
by Hvidtfeldt et al. [46] found a reduced risk of coronary
heart disease in all ages, and our null findings in the older
age group may be due to unequal sample size distributions
for each level, reducing power in the sparser strata. The
lower risk of CVD mortality in the current study remained
in younger, overweight, unhealthy, and fit men. Similarly,
the protective eﬀect of alcohol consumption has been shown
in populations with poor health status including men with
hypertension [37], cardiovascular disease [47], and vascular
disease including diabetes mellitus [2].
Interestingly, when the data were analyzed by fitness
levels, fit men had lower risks of CVD mortality with larger
alcohol consumption than did unfit men. This may be due

to a synergistic eﬀect as alcohol and fitness aﬀect similar
pathways such as lipid, glucose, and cholesterol metabolism.
It also may be due to fit nondrinkers having a higher risk due
to other latent variables (they may have been high risk and
as a result began to exercise and quit drinking). The diﬀerent
risks associated with stratified populations confirm that the
relationship between alcohol and mortality is complex and
may vary between population subgroups.
4.5. Type of Alcohol. The results of the sensitivity analysis
found no significant changes in risk of all-cause mortality
when alcohol consumption was stratified by type, consistent
with the overall analysis. Although for CVD mortality,
our findings suggest that there was a reduction in risk
of about 29% for moderate consumption of beer, wine,
and liquor. This reduction was most consistent with liquor
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Table 7: Hazard ratios of CVD mortality stratified by types of alcohol beveragea , Aerobics Center for Longitudinal Study (ACLS), 1974–2002.

Beer (n = 23, 728)
No.
No. of Cases
Hazard ratios
Wine (n = 21, 997)
No.
No. of Cases
Hazard ratios
Liquor (n = 20, 416)
No.
No. of Cases
Hazard ratios

Alcohol consumption (drinks/week)
Quartile 2
Quartile 3

Non Drinkers

Quartile 1

Quartile 4

4870
128
1.00 (referent)

3854
43
0.71 (0.50, 1.02)

4876
104
0.76 (0.57, 1.01)

5779
64
0.72 (0.52, 0.995)

4349
75
1.06 (0.78, 1.45)

4870
128
1.00 (referent)

4091
55
0.76 (0.55, 1.05)

4999
104
0.70 (0.53, 0.93)

4175
55
0.74 (0.53, 1.04)

3862
64
0.89 (0.64, 1.23)

4870
128
1.00 (referent)

3111
36
0.74 (0.51, 1.07)

5022
112
0.71 (0.55, 0.93)

3562
74
0.69 (0.50, 0.93)

3851
144
0.98 (0.75, 1.27)

a

Adjusted for age (in years), year of examination, BMI (kg/m2 ), smoking (current smoker or not), family history of CVD (yes or no), maximal treadmill time
(min), and remaining type of alcohol.

consumption. Beulens et al. [37] also found that liquor
drinkers had the strongest association with decreased risk
of myocardial infarction. There have been inconsistencies,
however, when comparing the types of alcohol on mortality.
While several epidemiologic studies, including the current
study, have found no diﬀerences in risk between types of
alcohol consumed [1, 43, 48, 49], others have suggested
unique cardioprotection from wine [50]. Experimental studies have shown the ethanol in wine to have additional
protection compared to dealcoholized red wine [51]. The
diﬀerential eﬀects may depend on gender. Compared to dealcoholized beverages, women had increased adiponectin (an
anti-inflammatory factor also shown to be associated with
improved insulin sensitivity) after drinking red wine, while
men had increased levels after drinking liquor and beer [52].
4.6. Strengths and Limitations. Strengths of this study are
inclusion of several potential confounders including measures of fitness and psychological variables, lengthy followup in a large cohort, exploration of relationships by health
risk factors, and stratification by alcohol types. The limitations include that the sample was only men from the
Cooper Clinic in Dallas, Tex, USA, predominantly white,
and of middle to high incomes, limiting generalizations to
entire populations. However, the homogenous population
does eliminate potential confounding from gender [4] and
race [5, 28], both of which have been shown to influence
the relationship between alcohol and mortality. Additionally,
this regional population is similar in physiologic variables
to other North American populations [53]. The mean age
of 43 at baseline with an average follow-up time of 16
years makes these findings particularly relevant for an aging
American population. When stratified by age, we did not
find a significant association in the older men, but this may
have been due to a small sample of men above 60. Future
studies are needed to confirm the lower levels of alcohol
consumption found to be protective in this study population.

Clearly, more work will be required in populations that diﬀer
in racial and ethnic composition to that of the ACLS.
While self-reported alcohol consumption has been validated [23], under or overreporting could have influenced
the trends in risk reduction in either direction. The format
of response did not allow assessment of varied drinking
patterns including daily frequency of alcohol consumption.
Studies have suggested that alcohol should be consumed in
small amounts over multiple occasions for health benefits
rather than binge drinking [54]. In the sensitivity analyses,
it was not possible to isolate single types of drinkers due to
low prevalence of single alcohol-type drinkers.
Despite adjustment for many confounders, confounding
may still exist in this and other prospective studies. One
potential confounder not adjusted for was diet, particularly
fat intake, which plays an established role in cardiovascular
outcomes. We did, however, measure and control for blood
cholesterol levels which is associated with dietary fat intake
[55].
Consistent with previous studies, we used nondrinkers
as the referent group [5, 43, 56]. Some researchers have
argued against using nondrinkers as the referent group due
to confounding predisposing conditions or other latent variables contributing to diﬀerential mortality risk independent
of alcohol consumption [10]. Mukamal et al. [14] found
that nondrinkers are more likely to be in poor health,
obese, of low income, or physically inactive; however, they
did not exclude or report whether the participants had
preexisting vascular disease. In contrast, when adjusted for
preexisting disease (excluded or controlled for in our model),
Wannamethee and Shaper [10] found ex-drinkers and lifelong nondrinkers had equal CVD mortality and almost equal
all-cause mortality. When Hart and Smith [56] examined
the health status of nondrinkers to drinkers, they did not
diﬀer substantially. Friesema et al. [57] found that the inverse
relationship between alcohol consumption and mortality
could not be explained by health status alone. Potential
confounding would have a less likely eﬀect on CVD mortality
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as Klatsky and Udaltsova [5] found that the excess mortality
seen in nondrinkers is not related to CVD.
This study attempted to account for any “sick quitters”
(former drinkers who stopped due to an adverse health
condition) through in-depth baseline assessments to rule
out underlying disease and adjustment for confounders. In
asymptomatic men, especially with risk factors for CVD,
exercise testing has been shown to be a valid predictor of
future CVD mortality [58] beyond reported risk factors [59].
In addition, we examined if the risk association varied by
levels of these risk factors (health status, age, BMI, and fitness
status).

5. Conclusion
We found a trend towards reduction in risk of all-cause
mortality with self-reported alcohol consumption and a
reduction in risk of CVD mortality with one to six drinks per
week, when adjusting for several potential confounders in a
large sample of men. The amount of alcohol consumption
associated with a reduced risk of CVD mortality was less than
the current public health recommendations of 1-2 drinks
per day. A lack of consensus on the amount and type of
alcohol for protective eﬀects and other potential harmful
consequences of alcohol abuse calls for caution when making
public health recommendations for alcohol consumption.
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intake and the risk of coronary heart disease in the Spanish
EPIC cohort study,” Heart, vol. 96, no. 2, pp. 124–130, 2010.
[2] J. W. J. Beulens, A. Algra, S. S. Soedamah-Muthu, F. L. J.
Visseren, D. E. Grobbee, and Y. van der Graaf, “Alcohol
consumption and risk of recurrent cardiovascular events and
mortality in patients with clinically manifest vascular disease
and diabetes mellitus: the Second Manifestations of ARTerial
(SMART) disease study,” Atherosclerosis, vol. 212, no. 1, pp.
281–286, 2010.
[3] J. M. Gaziano, T. A. Gaziano, R. J. Glynn et al., “Light-tomoderate alcohol consumption and mortality in the physicians’ health study enrollment cohort,” Journal of the American
College of Cardiology, vol. 35, no. 1, pp. 96–105, 2000.
[4] L. R. Harriss, D. R. English, J. L. Hopper et al., “Alcohol
consumption and cardiovascular mortality accounting for
possible misclassification of intake: 11-year follow-up of the

[12]
[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

Melbourne Collaborative Cohort Study,” Addiction, vol. 102,
no. 10, pp. 1574–1585, 2007.
A. L. Klatsky and N. Udaltsova, “Alcohol drinking and total
mortality risk,” Annals of Epidemiology, vol. 17, no. 5, pp. S63–
S67, 2007.
A. Sadakane, T. Gotoh, S. Ishikawa, Y. Nakamura, and K.
Kayaba, “Amount and frequency of alcohol consumption and
all-cause mortality in a Japanese population: the JMS cohort
study,” Journal of Epidemiology, vol. 19, no. 3, pp. 107–115,
2009.
I. Suh, B. J. Shaten, J. A. Cutler, and L. H. Kuller, “Alcohol use
and mortality from coronary heart disease: the role of highdensity lipoprotein cholesterol,” Annals of Internal Medicine,
vol. 116, no. 11, pp. 881–887, 1992.
W. Sun, C. M. Schooling, W. M. Chan, K. S. Ho, T. H. Lam,
and G. M. Leung, “Moderate alcohol use, health status, and
mortality in a prospective Chinese elderly cohort,” Annals of
Epidemiology, vol. 19, no. 6, pp. 396–403, 2009.
M. J. Thun, R. Peto, A. D. Lopez et al., “Alcohol consumption
and mortality among middle-aged and elderly U.S. adults,”
The New England Journal of Medicine, vol. 337, no. 24, pp.
1705–1714, 1997.
S. G. Wannamethee and A. G. Shaper, “Lifelong teetotallers,
ex-drinkers and drinkers: mortality and the incidence of major
coronary heart disease events in middle-aged British men,”
International Journal of Epidemiology, vol. 26, no. 3, pp. 523–
531, 1997.
M. A. Collins, E. J. Neafsey, K. J. Mukamal et al., “Alcohol in
moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies,” Alcoholism:
Clinical and Experimental Research, vol. 33, no. 2, pp. 206–219,
2009.
A. L. Klatsky, “Alcohol and cardiovascular health,” Physiology
and Behavior, vol. 100, no. 1, pp. 76–81, 2010.
A. Di Castelnuovo, S. Costanzo, M. B. Donati, L. Iacoviello,
and G. de Gaetano, “Prevention of cardiovascular risk by
moderate alcohol consumption: epidemiologic evidence and
plausible mechanisms,” Internal and Emergency Medicine, vol.
5, no. 4, pp. 291–297, 2010.
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